STOCK TITAN

Soligenix Inc Financials

SNGX
FY2025 annual
Revenue Not reported for FY2025
Net Income -$11.1M -33.7% YoY
EPS (Diluted) -$2.14 YoY not available
Free Cash Flow -$10.3M YoY not available
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

This page shows Soligenix Inc (SNGX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SNGX FY2025

External financing rather than product revenue is carrying operations, with cash burn and R&D spending defining the business model.

In FY2025, financing inflows of $10.4M almost perfectly matched free cash burn of $10.3M, which is why cash finished near $7.9M instead of collapsing. The same pattern appeared in FY2024, when $7.8M of financing offset an $8.4M operating outflow, showing liquidity is being preserved by repeated capital raising rather than by commercial receipts.

The income statement behaves like a development-stage operation, not a scaled seller: FY2025 R&D was $7.5M while FY2024 revenue was only $119K. With sales still below $1M in both FY2023 and FY2024, profit swings mainly track research intensity and financing access rather than customer demand.

The balance sheet is less encumbered than a year ago: total liabilities fell to $3.9M from $4.8M. But that healthier liquidity posture still rests on external funding, because year-end cash did not cover FY2025 free cash burn and the current ratio’s rise to 2.4x reflects capital raised, not operating surplus.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Soligenix Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial
2/6

Soligenix Inc passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality No Cash Backing
N/A

Soligenix Inc reported a net loss of $11.1M while operations used $10.3M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Net Income
-$11.1M
YoY-33.7%

Soligenix Inc reported -$11.1M in net income in fiscal year 2025. This represents a decrease of 33.7% from the prior year.

EPS (Diluted)
-$2.14

Soligenix Inc earned -$2.14 per diluted share (EPS) in fiscal year 2025.

Revenue

Not reported for fiscal year 2025.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$10.3M

Soligenix Inc recorded an outflow of $10.3M in free cash flow in fiscal year 2025, representing a cash shortfall after capex.

Cash & Debt
$7.9M
YoY+1.5%
5Y CAGR-15.7%
10Y CAGR+4.9%

Soligenix Inc held $7.9M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
10M

Soligenix Inc had 10M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity
-209.8%
YoY-8.2pp

Soligenix Inc's ROE was -209.8% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.2 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not reported for fiscal year 2025.

Net Margin

Not reported for fiscal year 2025.

Capital Allocation

R&D Spending
$7.5M
YoY+43.3%
5Y CAGR-5.2%
10Y CAGR+3.3%

Soligenix Inc invested $7.5M in research and development in fiscal year 2025. This represents an increase of 43.3% from the prior year.

Capital Expenditures
$6K

Soligenix Inc invested $6K in capex in fiscal year 2025, funding long-term assets and infrastructure.

Share Buybacks

Not reported for fiscal year 2025.

SNGX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SNGX annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
RevenueN/AN/A$119K-85.8%$839K-11.5%$949K+15.1%$824K-65.1%$2.4M-49.0%$4.6M-11.7%$5.2M-3.5%$5.4M-48.0%$10.4M+19.2%$8.8M+24.5%$7.0M+118.4%$3.2M+2.5%$3.1M-59.0%$7.7M
Cost of RevenueN/AN/A$119K-83.9%$742K+34.7%$551K-24.4%$729K-60.0%$1.8M-49.0%$3.6M-22.4%$4.6M+6.7%$4.3M-48.9%$8.4M+22.5%$6.9M+29.5%$5.3M+108.9%$2.5M-1.9%$2.6M+23.0%$2.1M
Gross ProfitN/AN/A$0-100.0%$97K-75.6%$398K+316.3%$96K-82.2%$538K-49.3%$1.1M+65.1%$644K-42.6%$1.1M-44.3%$2.0M+6.8%$1.9M+9.1%$1.7M+154.3%$680K+23.3%$552K-90.1%$5.6M
R&D ExpensesN/A$7.5M+43.3%$5.2M+57.7%$3.3M-58.3%$7.9M-3.0%$8.2M-16.4%$9.8M+20.6%$8.1M+20.3%$6.8M+22.6%$5.5M+28.2%$4.3M-20.4%$5.4M+6.2%$5.1M+0.3%$5.1M+94.4%$2.6M-58.4%$6.3M
SG&A ExpensesN/A$4.4M+3.4%$4.2M-5.9%$4.5M-33.0%$6.7M+33.6%$5.0M+15.7%$4.3M+24.4%$3.5M+17.9%$3.0M-8.0%$3.2M-6.4%$3.4M-4.7%$3.6M+5.7%$3.4M+23.1%$2.8M+5.0%$2.6M+17.4%$2.2M
Operating IncomeN/A-$11.8M-25.5%-$9.4M-22.6%-$7.7M+45.9%-$14.2M-8.7%-$13.1M+29.5%-$18.6M-76.3%-$10.5M-16.4%-$9.1M-19.3%-$7.6M-33.0%-$5.7M+19.7%-$7.1M+33.9%-$10.8M-50.4%-$7.2M-52.6%-$4.7M-58.5%-$3.0M
Interest ExpenseN/AN/AN/AN/AN/A-$863K-2614.4%$34K-77.0%$149KN/AN/A$2K+127.6%-$8K-712.0%$1KN/AN/A$0
Income TaxN/A-$507K-23.8%-$409K+76.9%-$1.8M-53.1%-$1.2M-33.6%-$865K-3.3%-$837K-37.0%-$611KN/A-$417K+21.4%-$530K-8.4%-$489K+20.7%-$617K+17.8%-$750K-43.9%-$521K+9.2%-$574K
Net IncomeN/A-$11.1M-33.7%-$8.3M-36.1%-$6.1M+55.8%-$13.8M-9.9%-$12.6M+29.0%-$17.7M-89.1%-$9.4M-5.1%-$8.9M-24.5%-$7.1M-120.2%-$3.2M+58.6%-$7.8M-16.8%-$6.7M+33.3%-$10.1M-141.6%-$4.2M-75.0%-$2.4M
EPS (Diluted)-$2.14-$4.98-$12.66-$4.81-2.6%-$4.69-$0.64N/AN/A-$1.16-$1.34+55.3%-$3.00-$0.43+33.8%-$0.65N/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SNGX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SNGX annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$9.2M+3.0%$9.0M-8.5%$9.8M-31.4%$14.3M-46.9%$26.9M+35.1%$19.9M+155.8%$7.8M-25.9%$10.5M+9.9%$9.5M-7.0%$10.3M+39.0%$7.4M+6.2%$7.0M-15.9%$8.3M+75.7%$4.7M-42.8%$8.2M
Current Assets$8.8M+0.2%$8.8M-7.1%$9.5M-31.4%$13.9M-47.9%$26.6M+36.5%$19.5M+159.8%$7.5M-27.5%$10.3M+9.8%$9.4M-6.9%$10.1M+41.4%$7.2M+10.1%$6.5M-14.7%$7.6M+98.3%$3.8M-46.2%$7.1M
Cash & Equivalents$7.9M+1.5%$7.8M-7.4%$8.4M-36.8%$13.4M-48.7%$26.0M+39.4%$18.7M+244.5%$5.4M-39.7%$9.0M+15.0%$7.8M-11.0%$8.8M+78.2%$4.9M-10.9%$5.5M-5.7%$5.9M+74.5%$3.4M-44.0%$6.0M
Total Liabilities$3.9M-18.7%$4.8M-33.4%$7.3M-56.6%$16.8M+3.7%$16.1M0.0%$16.1M+155.6%$6.3M+50.0%$4.2M+30.4%$3.2M+12.5%$2.9M-61.2%$7.4M+4.2%$7.1M-29.2%$10.0M+769.6%$1.2M-19.4%$1.4M
Current Liabilities$3.7M-23.7%$4.8M-21.2%$6.2M-62.8%$16.5M+162.5%$6.3M+3.5%$6.1M-3.7%$6.3M+49.9%$4.2M+30.4%$3.2M+12.5%$2.9M-61.2%$7.4M+4.2%$7.1M-29.2%$10.0M+769.6%$1.2M-19.4%$1.4M
Long-Term DebtN/A$0-100.0%$1.0M$0N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Equity$5.3M+28.5%$4.1M+63.3%$2.5M+202.1%-$2.5M-123.0%$10.7M+186.6%$3.7M+156.8%$1.5M-76.8%$6.3M-0.6%$6.3M-14.6%$7.4M+40502.3%-$18K+88.1%-$154K+91.3%-$1.8M-149.8%$3.6M-47.7%$6.8M
Retained Earnings-$245.1M-4.7%-$234.0M-3.7%-$225.7M-2.8%-$219.6M-6.7%-$205.8M-6.5%-$193.2M-10.1%-$175.5M-5.6%-$166.2M-5.7%-$157.3M-4.8%-$150.1M-2.2%-$146.9M-5.6%-$139.0M-5.1%-$132.3M-8.2%-$122.3M-3.5%-$118.1M

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.

SNGX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

SNGX annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow-$9.7M-$10.3M-22.2%-$8.4M+2.3%-$8.6M+32.0%-$12.6M-7.7%-$11.7M-2.5%-$11.5M-52.5%-$7.5M-3.7%-$7.2M-11.3%-$6.5M-30.7%-$5.0M+7.5%-$5.4M-118.4%-$2.5M+44.7%-$4.5M-269.1%$2.6M+235.0%-$2.0M
Capital ExpendituresN/A$6KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash FlowN/A-$10.3MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Investing Cash FlowN/A-$6KN/AN/A-$13K-10.9%-$12K-65.0%-$7K+71.1%-$25K-2571.2%-$925+96.5%-$26K-268.0%-$7K+67.6%-$22K+92.7%-$301K-1597.1%-$18K-272.8%-$5K+96.9%-$153K
Financing Cash Flow$14.5M$10.4M+33.8%$7.8M+111.9%$3.7M+4668.9%$77K-99.6%$19.1M-22.8%$24.7M+516.1%$4.0M-52.4%$8.4M+51.1%$5.6M-37.0%$8.8M+84.0%$4.8M+97.2%$2.4M-65.1%$7.0MN/A$649K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

SNGX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

SNGX annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross MarginN/A0.0%-11.6pp11.6%-30.4pp41.9%+30.3pp11.6%-11.2pp22.8%-0.1pp22.9%+10.7pp12.3%-8.4pp20.7%+1.4pp19.3%-2.2pp21.5%-3.0pp24.6%+3.5pp21.1%+3.6pp17.5%-54.9pp72.5%
Operating MarginN/A-7907.7%-917.1%-1500.5%-1589.2%-787.8%-227.7%-172.8%-139.8%-54.6%+26.4pp-81.1%-152.8%-222.0%-149.2%-38.6%
Net MarginN/A-6953.1%-726.8%-1454.1%-1522.7%-749.7%-202.1%-169.8%-131.6%-31.1%+58.3pp-89.3%+5.9pp-95.2%-312.0%-132.4%-31.0%
Return on Equity-209.8%-8.2pp-201.5%+40.3pp-241.8%N/A-117.1%+355.7pp-472.7%+169.3pp-642.0%-500.3pp-141.7%-28.6pp-113.1%-69.2pp-43.9%N/AN/AN/A-117.2%-82.2pp-35.0%
Return on Assets-120.2%-27.6pp-92.6%-30.3pp-62.3%+34.4pp-96.6%-49.9pp-46.7%+42.2pp-88.9%+31.4pp-120.3%-35.5pp-84.8%-10.0pp-74.8%-43.2pp-31.6%+74.4pp-106.0%-9.6pp-96.4%+25.3pp-121.7%-33.2pp-88.5%-59.6pp-28.9%
Current Ratio2.39+0.6x1.82+0.3x1.55+0.7x0.84-3.4x4.22+1.0x3.20+2.0x1.19-1.3x2.46-0.5x2.92-0.6x3.52+2.6x0.97+0.1x0.91+0.2x0.76-2.6x3.32-1.7x4.98
Debt-to-Equity0.75+0.7x0.00-0.4x0.40N/A1.51-2.8x4.320.0x4.34+3.7x0.67+0.2x0.51+0.1x0.39N/AN/AN/A0.33+0.1x0.21

Not reported in any period shown, so not listed: FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Frequently Asked Questions

Is Soligenix Inc profitable?

No, Soligenix Inc (SNGX) reported a net income of -$11.1M in fiscal year 2025.

What is Soligenix Inc's earnings per share (EPS)?

Soligenix Inc (SNGX) reported diluted earnings per share of -$2.14 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Soligenix Inc's return on equity (ROE)?

Soligenix Inc (SNGX) has a return on equity of -209.8% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Soligenix Inc (SNGX) recorded an outflow of $10.3M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Soligenix Inc (SNGX) recorded an outflow of $10.3M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Soligenix Inc (SNGX) had $9.2M in total assets as of fiscal year 2025, including both current and long-term assets.

Soligenix Inc (SNGX) invested $6K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Soligenix Inc (SNGX) invested $7.5M in research and development during fiscal year 2025.

Soligenix Inc (SNGX) had 10M shares outstanding as of fiscal year 2025.

Soligenix Inc (SNGX) had a current ratio of 2.39 as of fiscal year 2025, which is generally considered healthy.

Soligenix Inc (SNGX) had a debt-to-equity ratio of 0.75 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Soligenix Inc (SNGX) had a return on assets of -120.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

At the end of fiscal year 2025, Soligenix Inc (SNGX) held $7.9M in cash, cash equivalents and investments, and reported an operating cash outflow of $10.3M over that year. Dividing the one by the other, the reported balance equals about 9 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Soligenix Inc (SNGX) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Soligenix Inc (SNGX) reported a net loss of $11.1M while operations used $10.3M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top